The invention is concerned with novel pyrrolidine-3,4-dicarboxamide derivatives of formula (I) ##STR00001## wherein R.sup.1 to R.sup.9 and X are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.

 
Web www.patentalert.com

< Inhibitors of checkpoint kinases

> Pyrimidine compound having dibenzylamine structure and medicament comprising the same

> Melanin concentrating hormone receptor antagonist

~ 00528